PERGOVERIS follitropin alfa (rch) / lutropin alfa (rch) powder for injection vial with diluent vial Australia - English - Department of Health (Therapeutic Goods Administration)

pergoveris follitropin alfa (rch) / lutropin alfa (rch) powder for injection vial with diluent vial

merck healthcare pty ltd - follitropin alfa, quantity: 150 iu; lutropin alfa, quantity: 75 iu - injection, powder for - excipient ingredients: sucrose; dibasic sodium phosphate dihydrate; monobasic sodium phosphate monohydrate; methionine; polysorbate 20; phosphoric acid; sodium hydroxide - pergoveris is indicated for the stimulation of follicular development in women with severe lh and fsh deficiency.

Pergoveris European Union - English - EMA (European Medicines Agency)

pergoveris

merck europe b.v.  - follitropin alfa, lutropin alfa - infertility, female - sex hormones and modulators of the genital system, - pergoveris is indicated for the stimulation of follicular development in women with severe luteinising-hormone (lh) and follicle-stimulating-hormone deficiency.in clinical trials, these patients were defined by an endogenous serum lh level < 1.2 iu/l.

LUVERIS lutropin alfa (rch) 75IU powder for injection vial with diluent vial Australia - English - Department of Health (Therapeutic Goods Administration)

luveris lutropin alfa (rch) 75iu powder for injection vial with diluent vial

merck healthcare pty ltd - lutropin alfa, quantity: 75 iu - injection, powder for - excipient ingredients: methionine; sodium hydroxide; phosphoric acid; sucrose; polysorbate 20; dibasic sodium phosphate dihydrate; monobasic sodium phosphate monohydrate - luveris in association with a recombinant follicle stimulating hormone (fsh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials, these patients were defined by an endogenous serum lh of less than 1.2 iu/l.

PERGOVERIS follitropin alfa (rch) /lutropin alfa (rch) 900 IU/450 IU in 1.44 mL solution for injection cartridge pre-assembled in a pen Australia - English - Department of Health (Therapeutic Goods Administration)

pergoveris follitropin alfa (rch) /lutropin alfa (rch) 900 iu/450 iu in 1.44 ml solution for injection cartridge pre-assembled in a pen

merck healthcare pty ltd - follitropin alfa, quantity: 625 iu/ml; lutropin alfa, quantity: 312.5 iu/ml - injection, solution - excipient ingredients: sucrose; poloxamer; methionine; phenol; arginine hydrochloride; dibasic sodium phosphate dihydrate; monobasic sodium phosphate monohydrate; sodium hydroxide; phosphoric acid; water for injections - pergoveris is indicated for the stimulation of follicular development in women with severe lh and fsh deficiency.

PERGOVERIS follitropin alfa (rch) /lutropin alfa (rch) 450 IU/225 IU in 0.72 mL solution for injection cartridge pre-assembled in a pen Australia - English - Department of Health (Therapeutic Goods Administration)

pergoveris follitropin alfa (rch) /lutropin alfa (rch) 450 iu/225 iu in 0.72 ml solution for injection cartridge pre-assembled in a pen

merck healthcare pty ltd - follitropin alfa, quantity: 625 iu/ml; lutropin alfa, quantity: 312.5 iu/ml - injection, solution - excipient ingredients: sucrose; poloxamer; methionine; phenol; arginine hydrochloride; dibasic sodium phosphate dihydrate; monobasic sodium phosphate monohydrate; sodium hydroxide; phosphoric acid; water for injections - pergoveris is indicated for the stimulation of follicular development in women with severe lh and fsh deficiency.

PERGOVERIS follitropin alfa (rch) /lutropin alfa (rch) 300 IU/150 IU in 0.48 mL solution for injection cartridge pre-assembled in a pen Australia - English - Department of Health (Therapeutic Goods Administration)

pergoveris follitropin alfa (rch) /lutropin alfa (rch) 300 iu/150 iu in 0.48 ml solution for injection cartridge pre-assembled in a pen

merck healthcare pty ltd - follitropin alfa, quantity: 625 iu/ml; lutropin alfa, quantity: 312.5 iu/ml - injection, solution - excipient ingredients: sucrose; poloxamer; methionine; phenol; arginine hydrochloride; dibasic sodium phosphate dihydrate; monobasic sodium phosphate monohydrate; sodium hydroxide; phosphoric acid; water for injections - pergoveris is indicated for the stimulation of follicular development in women with severe lh and fsh deficiency.

Pergoveris 150unit75unit powder and solvent for solution for injection vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pergoveris 150unit75unit powder and solvent for solution for injection vials

merck serono ltd - follitropin alfa; lutropin alfa - powder and solvent for solution for injection - 150unit ; 75unit

PERGOVERIS  Israel - English - Ministry of Health

pergoveris

merck serono ltd - follitropin alfa; lutropin alfa - powder and solvent for solution for injection - follitropin alfa 150 iu; lutropin alfa 75 iu - follitropin alfa - follitropin alfa - pergoveris is indicated for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials, these patients were defined by an endogenous serum lh level < 1.2 iu/l.

PERGOVERIS PRE-FILLED PEN Israel - English - Ministry of Health

pergoveris pre-filled pen

merck serono ltd - follitropin alfa; lutropin alfa - solution for injection - lutropin alfa 150 iu / 0.48 ml; follitropin alfa 300 iu / 0.48 ml - follitropin alfa - pergoveris is indicated for the stimulation of follicular development in adult women with sever lh and fsh deficiency.in clinical trials, these patients were defined by an endogenous serum lh level < 1.2iu/l